Cyclooxygenase-independent actions of cyclooxygenase inhibitors
about
sameAs
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitProstaglandin levels in seminal plasma and sperm extracts of the domestic turkey, and the effects of cyclooxygenase inhibitors on sperm mobilityPPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancerR-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoidsThe cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risksDifferential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro studyThe effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosaAspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitroAcetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activityInhibition of cAMP-dependent protein kinase A: a novel cyclo-oxygenase-independent effect of non-steroidal anti-inflammatory drugs in adipocytesNonsteroidal Anti-Inflammatory Drugs and the KidneySulindac enhances the killing of cancer cells exposed to oxidative stressSulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARαBifunctional Conjugates with Potent Inhibitory Activity Towards Cyclooxygenase and Histone DeacetylaseEosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Factors driving the aspirin exacerbated respiratory disease phenotype.Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory diseaseInterleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression.Ibuprofen slows migration and inhibits bowel colonization by enteric nervous system precursors in zebrafish, chick and mouse.Novel pathway of salicylate degradation by Streptomyces sp. strain WA46.PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice.NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/SalicylatesHigh-Dose Ibuprofen in Cystic Fibrosis.NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells.Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic deathAA/12-Lipoxygenase Signaling Contributes to Inhibitory Learning in Hermissenda Type B Photoreceptors.Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. A double blind randomized controlled trial.Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism.Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.Prostaglandin dehydrogenase (PGDH) in granulosa cells of primate periovulatory follicles is regulated by the ovulatory gonadotropin surge via multiple G proteins.Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.Ribes fasciculatum var. chinense Attenuated Allergic Inflammation In Vivo and In Vitro.The efficacy of parecoxib on systemic inflammatory response associated with cardiopulmonary bypass during cardiac surgery.
P2860
Q24604121-862FE9EC-54DF-4A4E-B46B-33F38F99C4F5Q24791548-B6453AF1-355B-40DC-87A1-5FBEB739AFE7Q26738811-02CA9BD8-FC78-41AD-B1BD-BA8B9F3F0D07Q27026428-72505133-6E58-4105-A253-2748B9FD4B1AQ27329150-B62815E0-A431-41D6-AAA2-9BD83688520BQ28193254-C3525B6D-9CC3-478E-9512-76D6C0DC5CE1Q28193949-1F381A47-3285-4A8F-8705-4842D5914F96Q28194351-81CA8CC3-0AD2-4AF6-8C8F-CD205B3F0235Q28210119-B9039B36-EB3E-4D7C-BBBF-D3BAFCD47346Q28219439-F283C110-5413-4310-835A-0AA82A786DE7Q28221685-E287CC2D-921B-442C-9F7A-E5F1819BD05BQ28386844-CBE85ECF-0038-4579-9186-B10CE5C734DFQ28475579-8D00CD37-3CF1-46EE-BD2E-C2AA0D47C347Q28479206-3F4E2CEA-BC27-435D-883F-A9C291A7E412Q29248227-0CE0DE7D-BF3A-4F0B-900B-81F3233B7EE4Q30276354-E831E394-DFF1-4179-B680-78F964A470B8Q30300955-8DA99A86-B828-4907-B840-2F3252890BBCQ30384450-2148597E-B00D-41DE-850D-2937AFD3AB08Q30428747-A9C57EA0-1DDB-479F-8A1E-00CEE04DB6C1Q30493291-5F642DC7-4F82-4E87-BA01-74C659BA4AC5Q30755598-BF2532AC-3FB3-4AE1-AF48-A9559FA5CD30Q33199036-51887DED-A669-4A13-B64B-056F980E3841Q33461994-77AE815E-E519-404F-A3D4-A695BDDA329FQ33640054-0FD6E0BD-7E11-4558-A20D-A52F13F99301Q33664334-886308F4-0363-4C09-A6C1-163AC10FC217Q33678000-59C8DDDE-8B93-4CB7-9BE3-78619D306C32Q33817129-843114A4-0E3F-4CFE-8137-14509F093D83Q33863351-192570C2-3D39-4A47-8F5B-C24D3AAB7340Q34085821-8D21C26F-023B-4156-B7B4-36DF9F391BE3Q34114652-CD389902-07CF-4863-AB4C-6B3196D2DFC4Q34134282-DCBBFD02-38AE-4FCC-AC7F-A465A531F0A5Q34201207-CB4333E9-C77C-443D-B660-1AC4D253928AQ34245387-EA923DEE-51D2-4B36-A87B-548C7DD973D3Q34470467-0DC02B1E-42A9-47BB-B6B3-6F5181050EB0Q34521281-90390C80-87E2-4110-902E-6155308AE84CQ34547466-D3A95ED1-37FF-4CF1-BD5C-5DB0651AE12BQ34574657-4C7758BF-0637-4E1E-88E5-9A478A6B02BAQ34583187-7C73C7A2-37BC-4729-B35D-77119CE8FB2EQ34632888-0E0BF040-E51E-4746-B561-E82099E7C90CQ34640836-9C3D1238-7629-49E3-B9EA-821A3B568CE4
P2860
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@ast
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@en
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@nl
type
label
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@ast
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@en
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@nl
prefLabel
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@ast
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@en
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@nl
P3181
P356
P1433
P1476
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
@en
P2093
G Geisslinger
J Pfeilschifter
P304
P3181
P356
10.1096/FJ.01-0390REV
P407
P577
2001-10-01T00:00:00Z